- Home
- REVB vs SBET Comparison
REVB vs SBET Comparison
Compare REVB & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVB
- SBET
- Stock Information
- Founded
- REVB 2020
- SBET 1995
- Country
- REVB United States
- SBET United States
- Employees
- REVB N/A
- SBET N/A
- Industry
- REVB Biotechnology: Pharmaceutical Preparations
- SBET Computer Software: Prepackaged Software
- Sector
- REVB Health Care
- SBET Technology
- Exchange
- REVB Nasdaq
- SBET Nasdaq
- Market Cap
- REVB 2.2M
- SBET 1.8M
- IPO Year
- REVB N/A
- SBET 1997
- Fundamental
- Price
- REVB $0.86
- SBET $40.14
- Analyst Decision
- REVB
- SBET
- Analyst Count
- REVB 0
- SBET 0
- Target Price
- REVB N/A
- SBET N/A
- AVG Volume (30 Days)
- REVB 2.8M
- SBET 5.7M
- Earning Date
- REVB 05-08-2025
- SBET 05-15-2025
- Dividend Yield
- REVB N/A
- SBET N/A
- EPS Growth
- REVB N/A
- SBET N/A
- EPS
- REVB N/A
- SBET N/A
- Revenue
- REVB N/A
- SBET $3,428,134.00
- Revenue This Year
- REVB N/A
- SBET N/A
- Revenue Next Year
- REVB N/A
- SBET N/A
- P/E Ratio
- REVB N/A
- SBET N/A
- Revenue Growth
- REVB N/A
- SBET N/A
- 52 Week Low
- REVB $0.77
- SBET $2.26
- 52 Week High
- REVB $60.80
- SBET $124.12
- Technical
- Relative Strength Index (RSI)
- REVB 20.22
- SBET 57.71
- Support Level
- REVB $0.78
- SBET $45.61
- Resistance Level
- REVB $1.15
- SBET $82.70
- Average True Range (ATR)
- REVB 0.23
- SBET 17.07
- MACD
- REVB -0.15
- SBET 2.08
- Stochastic Oscillator
- REVB 3.38
- SBET 32.15
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.